The Greens are calling on the Queensland Government to accept the advice of Australia’s leading medical experts and urgently scrap its ban on gender-affirming care for young trans people.
Earlier today, the National Health and Medical Research Council (NHMRC) released interim advice on the use of puberty suppressants, also known as puberty blockers, in the care of young people experiencing gender incongruence.
Puberty suppressants are medications that temporarily pause the development of physical characteristics driven by gonadotropin-releasing hormones (GnRH) in the body. They may be prescribed while a young person decides whether to begin hormone treatment, delay treatment, or before undergoing certain gender-affirming surgeries. The medications were first developed to treat precocious puberty, the early onset of puberty, and have been in use since the 1970s.
The advice recommends puberty suppressants as a treatment option for young people who have commenced puberty, have gender incongruence, and are assessed as suitable. Decisions should be made jointly by the young person, their parents or carers, and their clinicians.
Notably, the advice states that a young person does not need to express distress about their gender incongruence in order to access treatment.

Australian Greens LGBTIQA+ spokesperson Senator Nick McKim said it was time for the Queensland Government to reverse its ban on the use of puberty blockers.
“The Supreme Court, the government’s own independent review, and now Australia’s top medical experts have all shown there is no legal or medical basis for the Queensland Government’s actions.
“Access to quality healthcare and the ability to make our own medical decisions are human rights.
“Decisions about medicine should only ever be a matter for doctors and patients. Culture warriors and transphobes around the country need to back off and get out of the way,” Senator McKim said.
Queensland Greens MP Michael Berkman also called on the Queensland Government to act on the updated advice.
“Australia’s top experts have thoroughly debunked the anti-trans lobby and the LNP’s ideologically motivated healthcare ban.
“The Premier and the Health Minister can no longer hide behind ‘waiting for the evidence’.
“Tim Nicholls must accept the evidence, apologise to the trans community and immediately reinstate gender health services in Queensland.
“This report also raises questions about whether the government’s ban breaches Queensland laws that prohibit conversion practices, potentially exposing taxpayers to costly legal action,” Berkman said.
While the advice has been welcomed by a wide range of organisations including ACON, LGBTIQ+ Health Australia, Equality Australia, Transcend, Headspace and AusPATH, it has also drawn criticism from opponents of gender-affirming healthcare.
Professor Gary Geelhoed, a former Western Australian chief medical officer and prominent critic of gender-affirming healthcare, accused the committee behind the review of being biased.
“When you look at the composition of this committee, it was more or less set to produce this result. There was no real attempt to look at it objectively,” Professor Geelhoed told The Australian newspaper.
“These people would have been looking at the information, desperately looking for evidence over the last five or 10 years to show what they were doing was justified and they haven’t found it,” he said.
“But they managed to come up with a statement here that justifies them continuing business as usual, so the result is there will be young children being medicalised for life, maybe having their bodies altered, because of the stupidity of the decision being made.”
Jillian Spencer, the adolescent and child psychologist who parted ways with Queensland Health over her views on gender treatments, has also criticised the report and questioned why medical professionals with experience treating young people with gender dysphoria had been allowed to be part of the review team.
The NHMRC has said its advice was developed through a systematic review of the available evidence and in accordance with its standard guideline development processes, with input from clinicians, researchers and people with lived experience.





